Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs

The dog days of summer are here and IPO activity has slowed, but that hasn’t stopped some biotech companies from securing a place in the line leading to Wall Street. Late Friday, SpringWorks Therapeutics and Satsuma Pharmaceuticals filed paperwork to go public.